Beauty Health: Time For The Rally To Get Some Beauty Rest

Nov. 11, 2021 12:26 AM ETThe Beauty Health Company (SKIN)6 Comments


  • Beauty Health reported Q3 earnings highlighted by strong growth momentum for its HydraFacial skin treatment system.
  • Shares sold off on the report, with the market likely focusing on higher operating costs which pressured the adjusted EBITDA.
  • While Beauty Health remains an impressive growth story, a lofty valuation and earnings uncertainty likely limit the near-term upside in the stock.
  • Looking for a portfolio of ideas like this one? Members of Conviction Dossier get exclusive access to our model portfolio. Learn More »
Young woman having a collagen induction therapy

domoyega/E+ via Getty Images

The Beauty Health Company (NASDAQ:SKIN) commercializes the "HydraFacial" skin treatment system and related personal care products. The company has generated strong growth over the last two decades, largely creating the category for non-invasive skin resurfacing becoming a standard in the spa and beauty

Add some conviction to your trading! We sort through +4,000 ETFs/CEFs along with +16,000 U.S. stocks/ADRs to find the best trade ideas. Click here for a two-week free trial and explore our content at the Conviction Dossier.

This article was written by

Dan Victor, CFA profile picture
Outside-the-box trade ideas through a powerful multi-sector strategy.

BOOX Research is now Dan Victor, CFA

15 years of professional experience in capital markets and investment management at major financial institutions.

Check out our private marketplace newsletter service *Conviction Dossier* for curated trade ideas.

Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You

Comments (6)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.